Our
story
Since 1993, D.M.G. ITALIA has established itself in increasingly competitive markets thanks to the usefulness of its product.
Company
In a continuously transforming global context, our company has followed a path of constant evolution, marked by objectives and new challenges.
Who we are
WeareanItalianpharmaceuticalcompanyspecializedintheresearch,developmentandcommercializationofmedicaldevices,foodsupplementsanddrugs.Ourmainobjectiveistoofferinnovative,safeandeffectivetherapeuticsolutionstopatientsandhealthcareprofessionals,aswellasnewbusinessopportunitiestoItalianandinternationalpharmaceuticalcompanies.Wesharewithourpartnerssolidknow-how,developedovertheyears,tohelpthemgrowtheirbusinessworldwide.
Milestones
Our story began in 1993 with a clear goal: being useful through innovation. Since our foundation, we have built a path of constant growth, including internationalization.
Every goal achieved represents a new starting point.
Our timeline shows how we became a leader in the sector: from international expansion to continuous innovation of our production processes.
D.M.G. ITALIA S.r.l. is established, founded by Luigi Mercuri and Antonio De Nisi. In the same year, Council Directive 93/42/EEC on medical devices (MDD 93/42) is published in the GUCE (Official Journal of the European Communities).
D.M.G. ITALIA introduces its first over-the-counter products, Texoftal and Rimgel, pioneering single-use eye-cleansing wipes in Europe.
D.M.G. ITALIA prepares for the launch in the Italian market of RINOPANTEINA, the first CE-marked medical device, expanding its portfolio into otorhinolaryngology (ENT).
D.M.G. ITALIA enters the vitreous humour segment with the market launch of VITREOSAN.
Directive 93/42/EEC is implemented in Italy through Legislative Decree No. 46 of 24 February 1997.
D.M.G. ITALIA consolidates its position in ophthalmology with VISCOBLAST.
D.M.G. ITALIA launches GASTROTUSS 500 ml syrup, the first oral medical device in Europe for the treatment of gastroesophageal reflux; it remains a market leader to this day.
D.M.G. ITALIA signs its first international distribution agreement and, in the same year, relocates its headquarters from Rome to Pomezia, inaugurating its first manufacturing site.
Within a short timeframe, local-law companies are established: DMG Bulgaria, DMG Turkey, and DMG Poland.
D.M.G. ITALIA inaugurates a new 3,300 m² warehouse.
In response to rapid growth, D.M.G. ITALIA builds 2,200 m² of new offices at its current headquarters on Via Nicaragua (Pomezia).
On 25 May 2017, the European Medical Devices Regulation (MDR) enters into force, with 26 May 2021 as its date of application. The MDR is intended to replace the MDD.
Following the entry into force of the MDR, D.M.G. ITALIA promptly begins the recertification of its entire product range.
D.M.G. ITALIA expands its Group with the addition of a new manufacturing entity.
With its growing presence in the Italian and international markets, D.M.G. ITALIA initiates a significant expansion of its office and production spaces. The Company further grows and strengthens its operations with the integration of a new manufacturing entity located in another province.
What we have achieved
Through the phases of planning, organization, control and analysis of results, our R&D team manages projects aimed at creating the added value that has allowed us to record constant growth over the years.
in 76+ Countries
in various pharmaceutical forms and presentations
Otorhinolaryngology, Pediatrics, Ophthalmology, Gastroenterology
where our products are distributed
This screen contributes to energy saving when you are away or inactive.
Move the mouse or press any key to continue